Investor Relations Johnson & Johnson: Pharmaceutical Business Review

 

Health & Medicine Golimumab for psoriatic arthritis

Golimumab for psoriatic arthritis This document posted April 2011 Golimumab for psoriatic arthritis Product: GOLIMUMAB (Simponi®) Class of drugs: biologic response modifiers;